• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Asia Pacific Lancet Pen Needels Market Size

    ID: MRFR/MED/0187-HCR
    90 Pages
    Kinjoll Dey
    October 2025

    Lancet and Pen Needles Market Research Report, By Therapy (Insulin, (GLP-1), Growth Hormones), Gauge (17/18G, 21G, 23G), Needle Length (4mm, 8mm, 12mm), And End Users (Medical Institutions & Research Organizations) – The Asia Pacific Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Asia Pacific Lancet Pen Needels Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Asia Pacific Lancet Pen Needels Size

    Asia Pacific Lancet Pen Needels Market Growth Projections and Opportunities

    The ASIA PACIFIC LANCET AND PEN NEEDLES market is significantly influenced by the growing diabetes epidemic in the region. With a substantial increase in the number of individuals diagnosed with diabetes, there is a corresponding surge in the demand for lancets and pen needles for blood glucose monitoring and insulin administration, driving market growth. The LANCET AND PEN NEEDLES market in Asia pacific is shaped by progress in technology. The continual innovation with respect to the design of both lancet and pen needles, which are related to finer sample gauges, painless injection mechanisms, and improved safety measures leads to positive patient experience and compliance with diabetes management protocols. Though Asia Pacific on a continual basis experiences the developments in healthcare infrastructure, they are generally responsible for increased accessibility and utilization of diabetes management devices. The developments whereby, healthcare centers are being developed more often, especially in the global areas where economic growth is taking shape is also created a climate for uptake of lancets and pen needles into the clinical routine practice. Injection therapies for diabetes treatment, with insulin pens being one of the most popular choices, determine the amount of needles that are needed for pens. Established by the growing popularity in injecting healthcare, the trend for congruent self- administering pen needles changes the dynamics in the market. The emergence of patient driven healthcare and self-monitoring drives the demand for lancets and pen needles. The adoption of pen needles and lancets are increased in the Asia Pacific region due to the demand of convenient and user-friendly devices thus blood glucose monitoring and insulin administration. Public health programs and government initiatives that focus on diabetes control stimulate market development. The establishment of programs for the prevention and control of diabetes drives the adoption of these lancets and pen needles through subisidjie s, awareness campaigns, and the programs themselves. Healthcare spending alone is a vital factor affecting the LANCET AND PEN NEEDLES market, other factors are such as income revenue and insurance coverage. Economic stability and decided allocation of government budget on health care affects purchasing power of both purchasers and consumers. However, cultural specification and population health consciousness is shaping up lancets and pen needles adoption. As health consciousness is growing, there is a trend that people are willing to spend money on devices which allow them to monitor their blood glucose and administer insulin more regularly because such cultural values dictate that they promote wellness. There is a demographic shift towards an aging population in some Asia Pacific countries which contributes to the incidence of diabetes and the appetite for lancets and pen needles. The market for suitable products targeted for older adults is driven by the diabetes management devices necessary for the older adults. Intense competition for key players in the LANCET AND PEN NEEDLES market in the Asia Pacific forces the brand differentiation. Market competitors try to gain advantage by creating unique and interesting properties, quality of manufactured products and establishing a brand loyalty. The adoption of telehealth services and remote monitoring technologies in Asia Pacific influences the market. Remote monitoring capabilities in lancet and pen needle devices allow healthcare providers to track patient data and provide timely interventions, aligning with the growing trend of digital healthcare solutions.

    Asia Pacific Lancet Pen Needels Market Size Graph

    Market Summary

    The Asia-Pacific Lancet and Pen Needles market is projected to grow significantly from 1.95 USD Billion in 2024 to 4.93 USD Billion by 2035.

    Key Market Trends & Highlights

    Asia Pacific Lancet and Pen Needles Key Trends and Highlights

    • The market is expected to expand at a compound annual growth rate (CAGR) of 8.81% from 2025 to 2035.
    • By 2035, the market value is anticipated to reach 4.93 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 1.95 USD Billion, laying a strong foundation for future expansion.
    • Growing adoption of advanced pen needle technology due to increasing prevalence of diabetes is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.95 (USD Billion)
    2035 Market Size 4.93 (USD Billion)
    CAGR (2025-2035) 8.81%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    BD. (U.S.), Novo Nordisk A/S (Europe), Ypsomed (Europe), B. Braun Melsungen AG (Europe), HTL-STREFA (Europe), Terumo Corporation (Asia Pacific), Artsana S.p.A. (Europe), Owen Mumford Ltd. (Europe)

    Market Trends

    Asia Pacific Lancet Pen Needels Market Market Drivers

    Market Segment Insights

    Regional Insights

    Key Companies in the Asia Pacific Lancet Pen Needels Market market include

    Industry Developments

    February 2024: Eli Lilly hopes to launch its bestselling antidiabetic medication, specified as Mounjaro (tripeptide), which will be around early next year. Indian health regulatory bodies, including Mounjaro, are currently investigating this.

    According to Minister Mykhailo Fedorov for Digital Transformation in Ukraine, contracts will be signed first about the mass production of attack drones similar to Russian Lancet drones in February 2024. Among them is the kamikaze drone Lancet manufactured by ZALA Aero Group, which has a range of forty kilometers and belongs to Kalashnikov Concern’s large enterprise division, Russian Armaments Manufacturer.

    June 2023: Shilpa Biologicals Private Limited (SBPL), a wholly owned subsidiary of Shilpa Medicare Limited (SML), was granted marketing authorization for its Adalimumab injection in prefilled syringe (PFS). It is a biosimilar for high concentration adalimumab formulation for rheumatoid arthritis treatment.

    During CPHI Japan 2023, SHL Medical introduced Molly modular platform autoinjectors with pre-installed Needle Isolation Technology (NIT).

    September 2022: The Microsoft and Novo Nordisk partnership was announced in September 2022, merging computational services, cloud computing AI and knowledge thirst in drug development as well as Novo Nordisk’s data engineering services.

    On September 2022, Novo Nordisk acquired Forma Therapeutics. That company is committed to changing lives of Sickle cell disease (SCD) patients among other rare blood diseases.

    Market Segmentation

    Intended Audience

    • Pharmaceutical companies
    • Biotechnological institutes
    • Government and Private Laboratories
    • Research and Development (R&D) Companies
    • Medical Research Laboratories
    • Market Research and Consulting Service Providers 

    Asia Pacific Lancet and Pen Needles Market Overview

    • Pharmaceutical companies
    • Biotechnological institutes
    • Government and Private Laboratories
    • Research and Development (R&D) Companies
    • Medical Research Laboratories
    • Market Research and Consulting Service Providers 

    Key Players for Asia Pacific Lancet and Pen Needles Market

    • BD. (U.S.)
    • Novo Nordisk A/S (Europe)
    • Ypsomed (Europe)
    • B. Braun Melsungen AG (Europe)
    • HTL-STREFA (Europe)
    • Terumo Corporation (Asia Pacific)
    • Artsana S.p.A. (Europe)
    • Owen Mumford Ltd. (Europe)

    Report Scope

    Attribute/Metric Details
    Market Size 2030  USD 3.45 Billion 2032
    Compound Annual Growth Rate (CAGR) 12.67% 2032
    Base Year 2021
    Market Forecast Period 2024-2032
    Historical Data 2018 - 2021
    Market Forecast Units Value (USD Million)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Product, technology, application, and end-users.
    Geographies Covered Americas, Europe, Asia Pacific and the Middle East and Africa
    Countries Covered China, Japan, India, Australia, South Korea, Australia, Rest of Asia-Pacific
    Key Companies Profiled BD. (U.S.), Novo Nordisk A/S (Europe), Ypsomed (Europe), B. Braun Melsungen AG (Europe), HTL-STREFA (Europe), Terumo Corporation (Asia Pacific), Artsana S.p.A. (Europe), Owen Mumford Ltd. (Europe).
    Key Market Opportunities Key market opportunities in the Asia Pacific lancet and pen needles market include rising diabetes prevalence, increasing healthcare expenditure, and growing awareness about advanced diabetes management technologies.
    Key Market Dynamics The key market dynamics for the Asia Pacific lancet and pen needles market include rising diabetes prevalence, increasing adoption of self-monitoring blood glucose devices, technological advancements in needle design, growing awareness and patient education, and expanding healthcare infrastructure.

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    1. TABLE OF CONTENT
    2. Chapter 1. Report Prologue
    3. Chapter 2. Market Introduction
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    4. Chapter 3. Research Methodology
      1. Introduction
      2. Primary Research
      3. Secondary research
      4. Market Size Estimation
    5. Chapter 4. Market Dynamics
      1. Drivers
      2. Restrains
      3. Opportunities
      4. Challenges
      5. Macroeconomic Indicators
      6. Technology Trends & Assessment
    6. Chapter 5. Market Factor Analysis
      1. Porters Five Forces Analysis
        1. Bargaining Power of Suppliers
        2. Bargaining Power of Buyers
        3. Threat of New Entrants
        4. Threat of Substitutes
        5. Intensity of Rivalry
      2. Value Chain Analysis
      3. Investment Feasibility Analysis
      4. Pricing Analysis
    7. Chapter 6. Asia Pacific Lancet and Pen Needles, by Therapy
      1. Introduction
      2. Insulin
    8. Market Estimates & Forecast, 2017 – 2023
      1. Glucagon-Like Peptide-1 (GLP-1)
    9. Market Estimates & Forecast, 2017 – 2023
      1. Growth Hormones
      2. Others
    10. Chapter 7. Asia Pacific Lancet and Pen Needles, by Gauge
      1. Introduction
      2. 17/18G
      3. 21G
      4. 23G
    11. Market Estimates & Forecast, 2017 – 2023
      1. Others
    12. Chapter 8. Asia Pacific Lancet and Pen Needles, by Needle Length
      1. Introduction
      2. 4mm
      3. 8mm
      4. 12mm
      5. Others
    13. Chapter 9 Asia Pacific Lancet and Pen Needles, by End User
      1. Introduction
      2. Hospitals & Clinics
      3. Medical Institutions & Research Organizations
        1. Market Estimates & Forecast, 2017 – 2023
      4. Others
    14. Chapter 10. Asia Pacific Lancet and Pen Needles, by Region
      1. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia
        5. Republic of Korea
        6. Rest of Asia Pacific
    15. Chapter 11 Company Landscape
      1. Introduction
      2. Market Share Analysis
      3. Key Development & Strategies
        1. Key Developments
    16. Chapter 12 Company Profiles
      1. BD.
        1. Company Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      2. Novo Nordisk A/S
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
      3. Ypsomed
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
      4. B. Braun Melsungen AG
        1. Company Overview
        2. Product/Business Segment Overview
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
      5. HTL-STREFA
        1. Company Overview
        2. Product Overview
        3. Financial overview
        4. Key Developments
        5. SWOT Analysis
      6. Terumo Corporation
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
      7. Artsana S.p.A.
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      8. Owen Mumford Ltd.
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      9. Others
    17. Chapter 13 MRFR Conclusion
      1. Key Findings
        1. From CEO’s View Point
        2. Unmet Needs of the Market
      2. Key Companies to Watch
      3. Prediction of Lancet and Pen Needles industry
    18. Chapter 14 Appendix
    19. List of Tables and Figures
      1. LIST OF TABLES
      2. Table 1 Lancet and Pen Needles Industry Synopsis, 2020-2027
      3. Table 2 Asia Pacific Lancet and Pen Needles Market Estimates and Forecast, 2020-2027, (USD Million)
      4. Table 3 Asia Pacific Lancet and Pen Needles Market by Region, 2020-2027, (USD Million)
      5. Table 4 Asia Pacific Lancet and Pen Needles Market by Therapy, 2020-2027, (USD Million)
      6. Table 5 Asia Pacific Lancet and Pen Needles Market by Gauge, 2020-2027, (USD Million)
      7. Table 6 Asia Pacific Lancet and Pen Needles Market by Needle Length, 2020-2027, (USD Million)
      8. Table 7 Asia Pacific Lancet and Pen Needles Market by End Users, 2020-2027, (USD Million)
      9. Table 8 Japan Lancet and Pen Needles Market by Therapy, 2020-2027, (USD Million)
      10. Table 9 Japan Lancet and Pen Needles Market by Gauge, 2020-2027, (USD Million)
      11. Table 10 Japan Lancet and Pen Needles Market by Needle Length, 2020-2027, (USD Million)
      12. Table 11 Japan Lancet and Pen Needles Market by End Users, 2020-2027, (USD Million)
      13. Table 12 China Lancet and Pen Needles Market by Therapy, 2020-2027, (USD Million)
      14. Table 13 China Lancet and Pen Needles Market by Gauge, 2020-2027, (USD Million)
      15. Table 14 China Lancet and Pen Needles Market by Needle Length, 2020-2027, (USD Million)
      16. Table 15 China Lancet and Pen Needles Market by End Users, 2020-2027, (USD Million)
      17. Table 16 India Lancet and Pen Needles Market by Therapy, 2020-2027, (USD Million)
      18. Table 17 India Lancet and Pen Needles Market by Gauge, 2020-2027, (USD Million)
      19. Table 18 India Lancet and Pen Needles Market by Needle Length, 2020-2027, (USD Million)
      20. Table 19 India Lancet and Pen Needles Market by End Users, 2020-2027, (USD Million)
      21. Table 20 Republic of Korea Lancet and Pen Needles Market by Therapy, 2020-2027, (USD Million)
      22. Table 21 Republic of Korea Lancet and Pen Needles Market by Gauge, 2020-2027, (USD Million)
      23. Table 22 Republic of Korea Lancet and Pen Needles Market by Needle Length, 2020-2027, (USD Million)
      24. Table 23 Republic of Korea Lancet and Pen Needles Market by End Users, 2020-2027, (USD Million)
      25. Table 24 Rest of Asia Pacific Lancet and Pen Needles Market by Therapy, 2020-2027, (USD Million)
      26. Table 25 Rest of Asia Pacific Lancet and Pen Needles Market by Gauge, 2020-2027, (USD Million)
      27. Table 26 Rest of Asia Pacific Lancet and Pen Needles Market by Needle Lenght, 2020-2027, (USD Million)
      28. Table 27 Rest of Asia Pacific Lancet and Pen Needles Market by End Users, 2020-2027, (USD Million) LIST OF FIGURES
      29. Figure 1 Research Process
      30. Figure 2 Segmentation for Asia Pacific Lancet and Pen Needles Market
      31. Figure 3 Market Dynamics for Asia Pacific Lancet and Pen Needles Market
      32. Figure 4 Asia Pacific Lancet and Pen Needles Market Share, by Therapy 2020
      33. Figure 5 Asia Pacific Lancet and Pen Needles Market Share, by Gauge 2020
      34. Figure 6 Asia Pacific Lancet and Pen Needles Market Share, by Needle Lenght 2020
      35. Figure 7 Asia Pacific Lancet and Pen Needles Market Share, by End Users, 2020
      36. Figure 8 Asia Pacific Lancet and Pen Needles Market Share, by Region, 2020
      37. Figure 9 Asia Pacific Lancet and Pen Needles Market Share, by Country, 2020
      38. Figure 10 Asia Pacific Lancet and Pen Needles: Company Share Analysis, 2020 (%)
      39. Figure 11 BD.: Key Financials
      40. Figure 12 BD.: Segmental Revenue
      41. Figure 13 BD.: Geographical Revenue
      42. Figure 14 Novo Nordisk A/S: Key Financials
      43. Figure 15 Novo Nordisk A/S: Segmental Revenue
      44. Figure 16 Novo Nordisk A/S: Geographical Revenue
      45. Figure 17 Ypsomed: Key Financials
      46. Figure 18 Ypsomed: Segmental Revenue
      47. Figure 19 Ypsomed: Geographical Revenue
      48. Figure 20 B. Braun Melsungen AG: Key Financials
      49. Figure 21 B. Braun Melsungen AG: Segmental Revenue
      50. Figure 22 B. Braun Melsungen AG: Geographical Revenue
      51. Figure 23 HTL-STREFA: Key Financials
      52. Figure 24 HTL-STREFA: Segmental Revenue
      53. Figure 25 HTL-STREFA: Geographical Revenue
      54. Figure 26 Terumo Corporation: Key Financials
      55. Figure 27 Terumo Corporation: Segmental Revenue
      56. Figure 28 Terumo Corporation: Geographical Revenue
      57. Figure 29 Artsana S.p.A.: Key Financials
      58. Figure 30 Artsana S.p.A.: Segmental Revenue
      59. Figure 31 Artsana S.p.A.: Geographical Revenue
      60. Figure 32 Owen Mumford Ltd.: Key Financials
      61. Figure 33 Owen Mumford Ltd.: Segmental Revenue
      62. Figure 34 Owen Mumford Ltd.: Geographical Revenue

    Lancet and Pen Needles Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials